Empirical Finance’s United Therapeutics UTHR Stock Holding History

Empirical Finance’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$917K	Buy	3,192 +895	+39%	+$257K	0.05%	324
2025 Q1	$708K	Hold	2,297	–	–	0.04%	345
2024 Q4	$810K	Sell	2,297 -2,076	-47%	-$732K	0.05%	311
2024 Q3	$1.57M	Buy	4,373 +18	+0.4%	+$6.45K	0.09%	187
2024 Q2	$1.39M	Buy	4,355 +322	+8%	+$103K	0.09%	191
2024 Q1	$926K	Buy	4,033 +16	+0.4%	+$3.68K	0.06%	292
2023 Q4	$883K	Hold	4,017	–	–	0.06%	280
2023 Q3	$907K	Buy	4,017 +267	+7%	+$60.3K	0.07%	255
2023 Q2	$828K	Buy	3,750 +1,942	+107%	+$429K	0.06%	268
2023 Q1	$405K	Hold	1,808	–	–	0.04%	396
2022 Q4	$503K	Buy	1,808 +12	+0.7%	+$3.34K	0.05%	328
2022 Q3	$376K	Buy	+1,796	New	+$376K	0.04%	356
2021 Q4	–	Sell	-4,400	Closed	-$812K	–	467
2021 Q3	$812K	Sell	4,400 -5,387	-55%	-$994K	0.12%	168
2021 Q2	$1.76M	Sell	9,787 -12,324	-56%	-$2.21M	0.29%	67
2021 Q1	$3.36M	Hold	22,111	–	–	0.59%	28
2020 Q4	$3.36M	Hold	22,111	–	–	0.59%	28
2020 Q3	$2.23M	Sell	22,111 -3,795	-15%	-$383K	0.48%	44
2020 Q2	$3.14M	Buy	25,906 +221	+0.9%	+$26.7K	0.8%	16
2020 Q1	$2.44M	Buy	25,685 +3,935	+18%	+$373K	0.76%	17
2019 Q4	$1.92M	Sell	21,750 -3,393	-13%	-$299K	0.47%	30
2019 Q3	$2.01M	Buy	25,143 +16,809	+202%	+$1.34M	0.56%	30
2019 Q2	$651K	Buy	8,334 +44	+0.5%	+$3.44K	0.18%	100
2019 Q1	$973K	Buy	+8,290	New	+$973K	0.25%	84
2018 Q4	–	Sell	-20,867	Closed	-$2.67M	–	180
2018 Q3	$2.67M	Buy	20,867 +3,896	+23%	+$498K	0.66%	19
2018 Q2	$1.92M	Buy	16,971 +8,681	+105%	+$982K	0.49%	38
2018 Q1	$973K	Sell	8,290 -604	-7%	-$70.9K	0.25%	84
2017 Q4	$1.32M	Sell	8,894 -6,712	-43%	-$993K	0.43%	64
2017 Q3	$1.83M	Buy	15,606 +1,190	+8%	+$139K	0.63%	36
2017 Q2	$1.87M	Buy	14,416 +14	+0.1%	+$1.82K	0.72%	28
2017 Q1	$1.95M	Buy	14,402 +5,797	+67%	+$784K	0.91%	21
2016 Q4	$1.24M	Buy	+8,605	New	+$1.24M	0.83%	20